← Open Payments lookup

ALISON MOE: Open Payments

NPI 1417227448 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$205,153 in 470 payments from 23 companies in 2025. Trend: 2023 $22,436 · 2024 $130,622 · 2025 $205,153

Speaker / faculty: $136,637Travel & lodging: $44,789Consulting: $12,644Food & beverage: $11,084
CompanyPaymentsAmount
ABBVIE INC.198$130,642
Madrigal Pharmaceuticals153$68,690
Genentech USA, Inc.6$2,969
Celltrion USA Inc.8$603
Takeda Pharmaceuticals U.S.A., Inc.20$293
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$254
Janssen Biotech, Inc.17$253
GlaxoSmithKline, LLC.1$250
Ardelyx, Inc.12$221
Regeneron Healthcare Solutions, Inc.9$217

Products named: SKYRIZI, REZDIFFRA, RINVOQ, DUPIXENT, ZYMFENTRA, TREMFYA, XIFAXAN, IBSRELA.

Industry payments across GA — which companies pay providers there.